A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2011
At a glance
- Drugs AZD 8075 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 24 Aug 2011 Planned End Date changed from 1 Jun 2009 to 1 Jan 2009 as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 30 Jan 2009 New trial record